Latest filings (excl ownership)
REVOKED
Registration or securities revoked
26 Apr 19
8-K
Entry into a Material Definitive Agreement
1 Jul 16
8-K
Regulation FD Disclosure
10 Jun 16
8-K
Entry into a Material Definitive Agreement
13 May 16
8-K
Entry into a Material Definitive Agreement
8 Apr 16
NT 10-K
Notice of late annual filing
31 Mar 16
8-K
Entry into a Material Definitive Agreement
1 Mar 16
8-K
Entry into a Material Definitive Agreement
1 Dec 15
8-K
Entry into a Material Definitive Agreement
18 Nov 15
10-Q
2015 Q3
Quarterly report
16 Nov 15
8-K
Departure of Directors or Certain Officers
10 Nov 15
D
$3M in equity, sold $600K, 4 investors
9 Nov 15
8-K/A
Termination of a Material Definitive Agreement
28 Oct 15
8-K
Vaccinogen Appoints Michael G. Hagerman to its Board of Directors
6 Oct 15
8-K
Termination of a Material Definitive Agreement
6 Oct 15
D/A
Indefinite amount in equity, 7 investors
24 Aug 15
D
Indefinite amount in options / securities to be acquired
20 Aug 15
D
Indefinite amount in options / securities to be acquired, 7 investors
20 Aug 15
10-Q
2015 Q2
Quarterly report
14 Aug 15
10-Q
2015 Q1
Quarterly report
15 May 15
8-K
Entry into a Material Definitive Agreement
5 May 15
8-K
Vaccinogen Names Co-Founder and CEO Andrew L. Tussing as Chairman of the Board
5 May 15
8-K
Departure of Directors or Certain Officers
24 Apr 15
10-K
2014 FY
Annual report
15 Apr 15
NT 10-K
Notice of late annual filing
1 Apr 15
S-8
Registration of securities for employees
27 Feb 15
8-K
Departure of Directors or Certain Officers
20 Feb 15
8-K
Departure of Directors or Certain Officers
12 Feb 15
8-K
Vaccinogen Closes Second Tranche of $80 Million Financing
30 Jan 15
8-K
Entry into a Material Definitive Agreement
12 Jan 15
8-K
Entry into a Material Definitive Agreement
31 Dec 14
10-Q
2014 Q3
Quarterly report
14 Nov 14
8-K
Entry into a Material Definitive Agreement
22 Sep 14
8-K
Entry into a Material Definitive Agreement
16 Sep 14
8-K
Departure of Directors or Certain Officers
29 Aug 14
8-K
Entry into a Material Definitive Agreement
25 Aug 14
10-Q
2014 Q2
Quarterly report
19 Aug 14
NT 10-Q
Notice of late quarterly filing
15 Aug 14
8-K
Entry into a Material Definitive Agreement
4 Aug 14
10-Q
2014 Q1
Quarterly report
14 May 14
Latest ownership filings
SC 13G
Vaccinogen Inc
13 Feb 17
3/A
MICHAEL G HANNA JR
7 Jul 15
4
MICHAEL G HANNA JR
7 Jul 15
4
MICHAEL G HANNA JR
7 Jul 15
4
ANDREW TUSSING
7 Jul 15
SC 13G/A
Vaccinogen Inc
7 Jul 15
SC 13D
Vaccinogen Inc
1 May 15
SC 13G/A
Vaccinogen Inc
1 May 15
4
Anders Ture Georg Halldin
22 Apr 15
4
RONALD W KAISER
22 Apr 15
4
ANDREW TUSSING
22 Apr 15
4
Hakan Edstrom
22 Apr 15
4
BENJAMIN CARSON SR
22 Apr 15
4
MICHAEL G HANNA JR
22 Apr 15
SC 13D/A
Vaccinogen Inc
23 Jan 15
SC 13D
Vaccinogen Inc
3 Sep 14
SC 13D
Vaccinogen Inc
3 Sep 14
144
Notice of proposed sale of securities
27 Aug 14
144
Notice of proposed sale of securities
19 Aug 14
SC 13G
Vaccinogen Inc
14 Feb 14
SC 13G
Vaccinogen Inc
14 Feb 14
SC 13G
Vaccinogen Inc
14 Feb 14
SC 13G
Vaccinogen Inc
14 Feb 14
SC 13G
Vaccinogen Inc
14 Feb 14